Martins Eduardo Bruno 4

What Happened Martins Eduardo Bruno, Chief Medical Officer of Sagimet Biosciences Inc. (SGMT), sold 3,640 shares on February 10, 2026 at $5.36 per share for total proceeds of $19,511. The sale was to satisfy tax withholding obligations tied to the vesting of restricted stock units and was automatic, not at the Reporting Person’s discretion.

Key Details

• Transaction date: 2026-02-10; Price: $5.36 per share; Shares sold: 3,640; Total proceeds: $19,511.
• Transaction type: Sale (S) — reported as an open market or private sale; footnote F1 indicates the sale was to cover tax withholding on RSU vesting.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing date/accession: Form 4 filed Feb 12, 2026 (appears timely; no late-filing flag indicated).
• No 10b5-1 plan, gifts, option exercises, or other special plan noted in the provided details.

Context Sales to cover tax withholding on vested restricted stock units are routine and typically administrative (footnote F1 confirms the sales were automatic). Such transactions do not necessarily indicate the insider’s view on the company’s prospects. The transaction size here is modest ($19.5K) relative to typical insider trades.